Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Psychemedics Corp (PMD) Common Stock USD0.005

Sell:$9.10 Buy:$9.38 Change: $0.01 (0.11%)
NASDAQ:0.20%
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$9.10
Buy:$9.38
Change: $0.01 (0.11%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$9.10
Buy:$9.38
Change: $0.01 (0.11%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Contact details

Address:
125 Nagog Park Ste 200
ACTON
01720-3451
United States
Telephone:
+1 (800) 6288073
Website:
https://www.psychemedics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PMD
ISIN:
US7443752057
Market cap:
$49.65 million
Shares in issue:
5.52 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Raymond Kubacki
    Chairman of the Board, President, Chief Executive Officer
  • Charles Doucot
    Executive Vice President
  • Neil Lerner
    Vice President - Finance
  • Michael Schaffer
    Vice President - Laboratory Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.